Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Spinal muscular atrophy

Recruiting

InvestigationalNo placebo

Study of Apitegromab Treatment in Children Under 2 Years Old with Spinal Muscular Atrophy (SMA)

InvestigationalNo placebo

Belgium

Participants:0–17 years
Substances:Apitegromab

Contact Research Centre

Spinal muscular atrophy

Recruiting

Registered drugNo placebo

Study on the Early Use of Risdiplam for Children with Spinal Muscular Atrophy After Gene Therapy

Registered drugNo placebo

Germany

Participants:0–17 years
Substances:Risdiplam

Contact Research Centre

Spinal muscular atrophy

Not yet recruiting

InvestigationalNo placebo

Safety and Efficacy of Intrathecal BIIB115 in Infants with Spinal Muscular Atrophy Previously Treated with Onasemnogene Abeparvovec

InvestigationalNo placebo

Belgium

Participants:0–17 years
Substances:BIIB115

Contact Research Centre

Spinal muscular atrophy

Not yet recruiting

InvestigationalNo placebo

Study of BIIB115 in patients aged 15‑60 years with spinal muscular atrophy who are treatment‑naïve or previously treated with risdiplam

InvestigationalNo placebo

Finland

Participants:0–17 years · 18–64 years
Substances:BIIB115

Contact Research Centre

Spinal muscular atrophy

Not recruiting

Investigational

Study on the Safety and Tolerability of BIIB115 for Children with Spinal Muscular Atrophy Previously Treated with Gene Therapy

Investigational

Belgium

Participants:0–17 years · 18–64 years · Healthy volunteers
Substances:BIIB115

Contact Research Centre

Spinal muscular atrophy

Not recruiting

Registered drugNo placebo

Long-term Safety Study of Onasemnogene Abeparvovec for Patients with Spinal Muscular Atrophy

Registered drugNo placebo

Belgium

Participants:0–17 years · 18–64 years
Substances:Onasemnogene Abeparvovec

Contact Research Centre

Spinal muscular atrophy

Not recruiting

Registered drug

Study on the Safety and Efficacy of RO7204239 and Risdiplam for Patients with Spinal Muscular Atrophy

Registered drug

Belgium

Participants:0–17 years · 18–64 years

Contact Research Centre

Spinal muscular atrophy+1

Not recruiting

Registered drug

Study of Clenbuterol vs Placebo in Adult Patients with Spinal and Bulbar Muscular Atrophy (SBMA)

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Clenbuterol Hydrochloride

Contact Research Centre

Spinal muscular atrophy

Not recruiting

Investigational

Study of NMD670 tablets to improve muscle strength in adults with Type 3 spinal muscular atrophy who can walk

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Nmd670

Contact Research Centre

Spinal muscular atrophy

Not recruiting

Registered drugNo placebo

Study on the Safety and Pharmacokinetics of Risdiplam in Infants with Spinal Muscular Atrophy

Registered drugNo placebo

Belgium

Participants:0–17 years
Substances:Risdiplam

Contact Research Centre

Spinal muscular atrophy

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Risdiplam for Children with Spinal Muscular Atrophy After Gene Therapy

Registered drugNo placebo

Germany

Participants:0–17 years
Substances:Risdiplam

Contact Research Centre

Spinal muscular atrophy

Not recruiting

InvestigationalNo placebo

Study on Long-Term Safety and Effects of Apitegromab in Patients with Type 2 and Type 3 Spinal Muscular Atrophy Who Completed Previous Trials

InvestigationalNo placebo

Belgium

Participants:0–17 years · 18–64 years
Substances:Apitegromab

Contact Research Centre

Find therapies in clinical trials near you

17 trials match your criteria

Spinal muscular atrophy

Study of Apitegromab Treatment in Children Under 2 Years Old with Spinal Muscular Atrophy (SMA)

Spinal muscular atrophy

Study on the Early Use of Risdiplam for Children with Spinal Muscular Atrophy After Gene Therapy

Spinal muscular atrophy

Safety and Efficacy of Intrathecal BIIB115 in Infants with Spinal Muscular Atrophy Previously Treated with Onasemnogene Abeparvovec

Spinal muscular atrophy

Study of BIIB115 in patients aged 15‑60 years with spinal muscular atrophy who are treatment‑naïve or previously treated with risdiplam

Spinal muscular atrophy

Study on the Safety and Tolerability of BIIB115 for Children with Spinal Muscular Atrophy Previously Treated with Gene Therapy

Spinal muscular atrophy

Long-term Safety Study of Onasemnogene Abeparvovec for Patients with Spinal Muscular Atrophy

Spinal muscular atrophy

Study on the Safety and Efficacy of RO7204239 and Risdiplam for Patients with Spinal Muscular Atrophy

Spinal muscular atrophy+1

Study of Clenbuterol vs Placebo in Adult Patients with Spinal and Bulbar Muscular Atrophy (SBMA)

Spinal muscular atrophy

Study of NMD670 tablets to improve muscle strength in adults with Type 3 spinal muscular atrophy who can walk

Spinal muscular atrophy

Study on the Safety and Pharmacokinetics of Risdiplam in Infants with Spinal Muscular Atrophy

Spinal muscular atrophy

Study on the Effectiveness and Safety of Risdiplam for Children with Spinal Muscular Atrophy After Gene Therapy

Spinal muscular atrophy

Study on Long-Term Safety and Effects of Apitegromab in Patients with Type 2 and Type 3 Spinal Muscular Atrophy Who Completed Previous Trials

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.